HeraMED Limited (HMD.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -504.09 Thousand AUD | 4.5% |
| 2022 | -314.15 Thousand USD | -3.74% |
| 2021 | -302.82 Thousand AUD | 16.86% |
| 2020 | -364.22 Thousand AUD | -21.06% |
| 2019 | -300.86 Thousand AUD | -428.75% |
| 2018 | -56.9 Thousand AUD | -523.08% |
| 2017 | -9132.22 AUD | -35.78% |
| 2016 | -6725.88 AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 92.57 Thousand AUD | 0.0% |
| 2023 Q2 | -70.53 Thousand AUD | 0.0% |
| 2023 FY | -300 Thousand AUD | 4.5% |
| 2023 Q4 | -232.17 Thousand AUD | 0.0% |
| 2022 Q2 | -111.25 Thousand AUD | 0.0% |
| 2022 Q4 | -205.74 Thousand AUD | 0.0% |
| 2022 FY | -314.15 Thousand USD | -3.74% |
| 2021 FY | -302.82 Thousand AUD | 16.86% |
| 2021 Q4 | -147.05 Thousand AUD | 0.0% |
| 2021 Q2 | -155.19 Thousand AUD | 0.0% |
| 2020 Q4 | 4648.62 AUD | 0.0% |
| 2020 FY | -364.22 Thousand AUD | -21.06% |
| 2020 Q2 | -189.62 Thousand AUD | 0.0% |
| 2019 FY | -300.86 Thousand AUD | -428.75% |
| 2019 Q4 | -172.9 Thousand AUD | 0.0% |
| 2019 Q2 | -128.5 Thousand AUD | 0.0% |
| 2018 Q4 | 12.06 Thousand AUD | 0.0% |
| 2018 FY | -56.9 Thousand AUD | -523.08% |
| 2018 Q2 | -20.15 Thousand AUD | -0.0% |
| 2018 Q1 | -20.15 Thousand AUD | 0.0% |
| 2017 FY | -9132.22 AUD | -35.78% |
| 2017 Q4 | -20.15 Thousand AUD | 0.0% |
| 2016 FY | -6725.88 AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | 114.331% |
| Adherium Limited | -640.83 Thousand AUD | 21.338% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 100.934% |
| Atomo Diagnostics Limited | 1.43 Million AUD | 135.087% |
| Anteris Technologies Ltd | 2.51 Million AUD | 120.026% |
| Control Bionics Limited | 3.67 Million AUD | 113.725% |
| CardieX Limited | 10.1 Million AUD | 104.987% |
| Compumedics Limited | 26.06 Million AUD | 101.934% |
| Cochlear Limited | 1.69 Billion AUD | 100.03% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 104.438% |
| Cyclopharm Limited | 4.49 Million AUD | 111.209% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 104.493% |
| Nova Eye Medical Limited | 20.19 Million AUD | 102.496% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 74.705% |
| ImpediMed Limited | 9 Million AUD | 105.598% |
| InhaleRx Limited | 1.2 Million AUD | 141.867% |
| LBT Innovations Limited | -2.91 Million AUD | 82.719% |
| Micro-X Limited | 5.73 Million AUD | 108.787% |
| Neurotech International Limited | -5867.00 AUD | -8492.04% |
| OncoSil Medical Limited | 55.63 Thousand AUD | 1006.124% |
| PolyNovo Limited | 36.08 Million AUD | 101.397% |
| Respiri Limited | 456.91 Thousand AUD | 210.326% |
| SomnoMed Limited | 55.13 Million AUD | 100.914% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 111.764% |
| Uscom Limited | 3.11 Million AUD | 116.179% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | -85.933% |